How Will Aurora Cannabis Inc. (TSX:ACB) and Canopy Growth Corp. (TSX:WEED) Stand Out From the Pack?

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) and Aurora Cannabis Inc. (TSX:ACB) won’t be able to use branding or promotions soon. If that happens, how will each firm differentiate themselves from the pack?

| More on:

Many pot firms including Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) and Aurora Cannabis Inc. (TSX:ACB) have been trying to bring forth brand awareness in spite of imminent regulatory measures come legalization day.

Canadian regulators said “No!” to branded merchandise and celebrity endorsements, at least for now, as it’s hoped that such strict rulings will prevent minors from wanting to try marijuana once it finally gets the green light. As the finishing touches are made in preparation for national legalization day slated for October 17, 2018, how regulators plan to enforce the strict rules remains in question.

Most recently, Health Canada noted its disapproval of marijuana producer-sponsored events, although there are no formalized rules or penalties in the books as yet. Many licensed producers (LPs) appear to be willing to test the boundaries of the rules, which remain vague and clouded by a haze of marijuana smoke currently.

“We have reviewed all activities with counsel to ensure compliance and continue to work collaboratively with regulators in support of this shared objective,” said Caitlin O’Hara, Canopy Growth Communications Specialist.

Technically, no formal rules have been broken yet…

So, with sponsorships and branded products (like Canopy’s Tweed) on the market, will regulators be throwing some LPs in the penalty box once specific rules, laws, penalties and enforcement initiatives finally come to fruition?

My guess is no, but perhaps a slap on the wrist could be in the cards.

While Canopy and Aurora have taken risks that contravene the vague rules in place now, with nothing formalized, it’ll be hard to punish LPs given the rigorous enforcement procedures that haven’t been implemented. Technically, offenders could be subject to a license suspension, but at this point, I think LPs will treat the underdeveloped regulatory measures as the permission to test the boundaries until Health Canada finalizes its regulatory and enforcement plans.

Product differentiation remains key

Although branding is off limits come legalization day, it will ultimately determine who will become the Marlboro of the industry in the grander scheme of things. Product differentiation, I believe, will separate the real winners in the space from the losers. Brand awareness remains the number one goal for LPs in spite of Health Canada’s intent to keep marijuana a commodity within a perfectly competitive market.

Over time, I do believe branding will get the green light, but for now, the big cannabis firms are going to need to be creative when it comes to promoting themselves. As we inch closer toward legalization day, I suspect select LPs will test the boundaries of the rules to get an edge over peers.

Once Health Canada finally makes rules and disciplinary actions official, all LPs will have no choice but to follow the rules.

There are other ways to promote branding while remaining in compliance with the rules, however. Branded swag and subtle colours on packaging are but two examples of how firms like Canopy will promote themselves in the meantime.

Branded packaging will be disallowed initially, but there may be no specifics regarding the appearance of the packaging. Think subtle differentiating elements on packaging like the signature green-cap of Jamieson Wellness Inc. vitamins. You don’t even have to look at the label to know that it’s a Jamieson product.

I suspect LPs will do the same to differentiate themselves, whether it’s through use of memorable colours or generic images like in the case of the Time of Day signature product offered by Hydropothecary Corp.

For now, all we can do is wait and see which differentiation moves that the LPs take on as we learn more about rules and enforcement initiatives that regulators will lay out in the coming months.

Stay hungry. Stay Foolish.

Should you invest $1,000 in Bausch Health Companies right now?

Before you buy stock in Bausch Health Companies, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Bausch Health Companies wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Investing

Stethoscope with dollar shaped cord
Investing

1 Magnificent Healthcare Stock Down 46% to Buy and Hold Forever

This TSX healthcare technology stock is trading at a considerable discount but boasts substantial long-term growth potential. It can be…

Read more »

calculate and analyze stock
Investing

Where I’d Invest $6,000 in The TSX Today

I am bullish on these two TSX stocks due to their solid underlying businesses and healthy growth prospects.

Read more »

Silver coins fall into a piggy bank.
Stocks for Beginners

Where I’d Invest My Savings in the TSX Today

If you have some savings ready to invest, then these three investments are top choices among analysts.

Read more »

Dividend Stocks

This Canadian Monthly Dividend Stock Pays a Stunning 9% Yield

Pro REIT is a Canada-based real estate company that offers you a forward yield of 9% in 2025. Is this…

Read more »

clock time
Bank Stocks

1 Magnificent Financial Stock Down 23% to Buy and Hold Forever

This top TSX financial stock is trading well below its recent peak, but its long-term fundamentals remain rock solid.

Read more »

dividend growth for passive income
Bank Stocks

This Canadian Bank Pays 4.75% and Could Double Your Money by 2030

A Canadian bank is a top pick for its lucrative dividend and potential to double your money in five years.

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

How I’d Invest $7,000 in My TFSA for $660 in Tax-Free Annual Income

Canadians looking for ways to make the most of the new TFSA contribution room should consider investing in these two…

Read more »

oil and natural gas
Energy Stocks

1 Magnificent Canadian Energy Stock Down 23% to Buy and Hold for Decades

This oil and gas producer has increased its dividend annually for more than two decades.

Read more »